Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - attenuated
7
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Mononegavirales Vectors Expressing Chimeric Antigens
Human respiratory syncytial virus (RSV) continues to be the leading viral cause of severe acute lower respiratory tract disease in infants and children worldwide, and also is an important cause of morbidity and mortality in the elderly. A licensed vaccine or antiviral drug suitable for routine use remains unavailable. This invention relates to the use...
Published: 7/25/2024
|
Inventor(s):
Linda Brock
,
Ursula Buchholz
,
Peter Collins
,
Shirin Munir
Keywords(s):
Added
,
Attenuated
,
DA4BXX
,
DA4XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DD1XXX
,
DDXXXX
,
DEXXXX
,
DXXXXX
,
Expressing
,
F
,
Fusion
,
Gene
,
Highly
,
Human
,
Immunogenic
,
Macaques
,
MPV
,
Murine
,
PNEUMONIA
,
Protein
,
respiratory
,
RHESUS
,
RSV
,
Syncytial
,
virus
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
Application > Diagnostics
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing SARS-CoV-2 Spike Protein and Its Use
Vaccines for SARS-CoV-2 are increasingly available under emergency use authorizations; however, indications are currently limited to individuals twelve (12) years or older. They also involve intramuscular immunization, which does not directly stimulate local immunity in the respiratory tract, the primary site of SARS-CoV-2 infection, shedding and spread....
Published: 7/25/2024
|
Inventor(s):
Shirin Munir
,
Cindy Luongo
,
Peter Collins
,
Cyril Le Nouen
,
Xueqiao Liu
,
Ursula Buchholz
Keywords(s):
2
,
ACUTE
,
Attenuated
,
B/HPIV3
,
BOVINE/HUMAN
,
chimeric
,
CORONAVIRUS
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
DEXXXX
,
DXXXXX
,
Expression
,
GLYCOPROTEIN
,
PIV3
,
respiratory
,
S
,
SARS-CoV-2
,
SEVERE
,
spike
,
Syndrome
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
,
Application > Research Materials
Mononegavirales Vectors expressing Chimeric Antigens
Human respiratory syncytial virus (RSV) continues to be the leading viral cause of severe acute lower respiratory tract disease in infants and children worldwide. A licensed vaccine or antiviral drug suitable for routine use remains unavailable. This invention relates to the use of murine pneumonia virus (MPV), a virus to which humans normally are not...
Published: 7/25/2024
|
Inventor(s):
Peter Collins
,
Ursula Buchholz
,
Linda Brock
,
Shirin Munir
Keywords(s):
Added
,
Attenuated
,
DA4BXX
,
DA4XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DD1XXX
,
DDXXXX
,
DEXXXX
,
DXXXXX
,
Expressing
,
F
,
Fusion
,
Gene
,
Highly
,
Human
,
Immunogenic
,
Macaques
,
MPV
,
Murine
,
PNEUMONIA
,
Protein
,
respiratory
,
RHESUS
,
RSV
,
Syncytial
,
virus
Category(s):
Collaboration Sought > Collaboration
,
Application > Diagnostics
,
Application > Research Materials
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
Real-time RT-PCR assay for Detection of Live
Attenuated
Influenza Vaccine for A and B Viruses
Upon intranasal vaccination, live
attenuated
influenza vaccine (LAIV) viruses may replicate within the nose for several days. Current clinical diagnostic tests cannot distinguish between LAIV viruses and multiple influenza viruses in recently inoculated patients that present with respiratory symptoms. This poses a problem for the diagnosis and treatment...
Published: 7/25/2024
|
Inventor(s):
Stephen Lindstrom
,
Kai-Hui Wu
,
LaShondra Berman
,
Christine Warnes
,
Bo Shu
Keywords(s):
assay
,
Assays.
,
Attenuated
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
CDCRM
,
DA4XXX
,
Detection
,
Human
,
Including
,
INFLUENZA
,
LAIV
,
LAIV-A
,
LAIV-B
,
Listed LPM Surabian as of 4/15/2015
,
Live
,
NCIRD-ID
,
PCR
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
REAL-TIME
,
respiratory
,
RT-PCR
,
SPECIMENS
,
States.
,
United
,
Vaccine
,
Viruses
,
VLXXXX
,
WBXXXX
,
WIXXXX
,
XEXXXX
,
XHXXXX
,
YDXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
Application > Diagnostics
,
Application > Research Materials
,
ResearchProducts > Research Equipment
Biological/Research Material for H1N1 Influenza Virus Vaccine Research
Offered for licensing is a recombinant
attenuated
vaccinia virus, MVA, that expresses the haemagglutinin (HA) and nucleoprotein (NP) of influenza virus A/PR/8/34 (H1N1). The virus has been shown to stimulate protective immunity to influenza virus in mice. The materials can be used for research purposes and in particular in the area of influenza virus...
Published: 7/25/2024
|
Inventor(s):
Linda Wyatt
,
Bernard Moss
Keywords(s):
A/PR/8/34
,
Attenuated
,
AXXXXX
,
DCXXXX
,
DDXXXX
,
DXXXXX
,
EXPRESSES
,
H1N1
,
Ha
,
Haemagglutinin
,
INFLUENZA
,
MVA
,
Np
,
NUCLEOPROTEIN
,
RESEARCH MATERIAL
,
That
,
vaccinia
,
virus
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
Respiratory Syncytial Virus (RSV) Vaccines Based on Promoter-Proximate Attenuation
Available for licensing and commercial development is a patent estate and related biological materials for producing therapeutic or prophylactic vaccines against Respiratory Syncytial Virus (RSV). The claimed vaccine strategy relates to the engineering and creation of live-
attenuated
RSV vaccine candidates by shifting the position of one or more viral...
Published: 7/25/2024
|
Inventor(s):
Peter Collins
,
Brian Murphy
,
Ursula Buchholz
,
Stephen Whitehead
,
Christine Krempl
Keywords(s):
ATTENUATE
,
Attenuated
,
ATTENUATING
,
ATTENUATION
,
Chromosome 7, monosomy
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
Deletion 7
,
DXXXXX
,
GENES
,
Noonan syndrome
,
NS1
,
Promoter-proximal
,
RSV
,
RSV virus
,
RSV/PIV
,
Syncytial
,
Vaccine
,
Vaccine Design
,
VACCINE DEVELOPMENT
,
VACCINE VECTORS
,
vaccines
,
virus
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
Live
Attenuated
Zika Virus Vaccine
This application claims live
attenuated
Zika viruses and vaccines, attenuated chimeric Zika viruses and vaccines, and multivalent immunogenic compositions comprising Zika vaccines and vaccines for other flaviviruses. The chimeric Zika viruses claimed include a first nucleotide sequence encoding at least one structural protein from a Zika virus (ZIKV),...
Published: 7/25/2024
|
Inventor(s):
Sara Woodson
,
Anna Durbin
,
Alexander Pletnev
,
Konstantin Tsetsarkin
,
Stephen Whitehead
Keywords(s):
Attenuated
,
CANDIDATES
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
DXXXXX
,
Live
,
Vaccine
,
virus
,
Zika
Category(s):
Collaboration Sought > Collaboration
,
Application > Diagnostics
,
Application > Vaccines
,
Application > Research Materials
,
TherapeuticArea > Infectious Disease